Bioprocess Innovation Leaders Summit Speakers

Ronan O’Kennedy


ROK Bioconsulting

Dr O’Kennedy has over twenty years of experience in the biopharmaceutical sector having worked for large biopharmaceutical companies, CMOs and in academia.

Martin Hofmann

Managing Director


Elected a Fellow of the Royal Society of Chemistry and trained Chartered Chemist with 36 years of experience specialising

Dawid Suwała

Head of Cell Culture Plant

Polpharma Biologics S.A.

MSc Biotechnology background gained at University of Silesia in Katowice and Maria Skłodowska-Curie Memorial Cancer Center in Gliwice, Poland.

Ferran Sánchez

Market Development Manager


Experienced Market Development Manager with a demonstrated history of working in the biotechnology industry.

Samet Yildirim

Head of Global Technology & Innovation Management

Boehringer Ingelheim

Samet is the Head of Global Technology & Innovation Management in the Boehringer Ingelheim Biopharma Business Unit.

Uwe Gottschalk



Uwe Gottschalk is Chief Technology Officer (CTO) at Lonza Pharma/Biotech since June 2014.

Dorothee Ambrosius

Head of Biologicals Strategy

Boehringer Ingelheim

Dorothee joined the leadership team of Boehringer Ingelheim

Jochen B. Sieck

Senior R&D Manager


We developed a combined process featuring N-1 perfusion in a novel expansion medium and high cell density cryopreservation (HCDC)

Ralph Daumke

Market Manager LifeScience


Academic Studies: University of Applied Sciences Berlin, Biotechnology

Manuel J. T. Carrondo

Vice President


Full Professor, Chemical and Biochemical Engineering, Faculty of Sciences and Technology, Univ. Nova de Lisboa (1995-presently jubilated).

Rutger Douma

Senior Manager Operations Bioprocessing Technology

Janssen (Johnson & Johnson)

Rutger Douma holds an MSc from Wageningen University in Bioprocess Technology and obtained his PhD at Delft University of Technology on penicillin fermentations.

Marc Pompiati

Principal Scientist


Marc Pompiati has over 19 years of experience in biotechnology process development, tech transfer and technology development.

Michael Sokolov

Co-founder, COO


Dr. Michael Sokolov is a chemical engineer by training and a Scientist at ETH Zurich, where he also holds a Lecturer position for statistics for chemical engineers.

Sune Klint Andersen

Principal Scientist, Particle Engineering

Janssen Pharmaceutica NV

Main interests and professional experience include development of drying processes for biopharmaceuticals, small and large molecules, drug substance and product, excipients, scale-up.

Cleo Kontoravdi

Reader in Biosystems Engineering

Imperial College

Cleo Kontoravdi's interests lie in the area of biotechnology.

Leonardo Magneschi

Section Head Molecular Biology

Ingenza Ltd

Leonardo Magneschi obtained a Ph.D. in Plant and Microbial Biotechnology. After his Ph.D. he was awarded an Alexander von Humboldt postdoctoral fellowship to investigate biofuel production in algae.

Stephen Lock

Marketing and Market Development Manager


Dr. Stephen Lock obtained his PhD in Physical Organic Chemistry from the University College of Swansea in 1993 and is a chartered chemist and a member of the Royal Society of Chemistry.

Jens Vogel

President & CEO BI Fremont

Boehringer Ingelheim

Jens H. Vogel, Ph.D. is President and CEO of Boehringer Ingelheim Fremont Inc. Jens

Louis Boon

Chief Scientific Officer


Louis Boon received his Ph.D. in Biochemistry at the University of Amsterdam.

Francis Verhoeye

Global Pilot Operations Leader


Francis Verhoeye serves as Global Pilot Operations Lead at Zoetis and is managing at the international level the Pilot Network specialized

Jonathan Cartoux

Field Application Engineer Life Sciences EMEA


Mr. Cartoux joined Entegris in January 2018 as an Application engineering team.

Mark Lies

Senior Global Product Manager


Mark Lies is a Global Senior product Manager for Capillary Electrophoresis (CE).

Valentina C. Ciccarone

Director, Gene Expression Strategies

MacroGenics, Inc.

Ph.D. in Cell Biology from Fordham University and Sloan Kettering Cancer Center in New York.Director and Principal Scientist at MacroGenics, Inc. (2002- present).

Timothy Gardner

CEO and Founder


Timothy Gardner is the Founder and the CEO of Riffyn – a cloud and scientific services company that has produced the world’s first scientific process data system.

Justyna Adamczyk

Cell Culture Plant MS&T Manager

Polpharma Biologics S.A.

MSc in Biotechnology at Technical University of Lodz; 8 years of practical and theoretical experience in manufacturing of sterile and low bioburden monoclonal antibodies.

Felix Oehme

VP, Head of Biological Development

Bayer AG, Pharmaceuticals

Felix Oehme received his Ph.D. in Biochemistry at the University of Munich. He joined Bayer in 1999 and worked as a Head of Laboratory in cardiovascular and biologics research.

Sebastian HANS

Head of High Throughput Bioprocess Development

TU Berlin | Bioprocess Engineering

Sebastian Hans leads the High Throughput Bioprocess Development Group at the Department of Bioprocess Engineering at the TU Berlin since 2019.

Christoph Herwig

Head of Research Division Biochemical Engineering

TU Wien

Christoph Herwig, bioprocess engineer from RWTH Aachen, worked in industry in the design and commissioning of large chemical facilities prior to enter his interdisciplinary PhD studies at EPFL.

Judy Chou

SVP and Global Head of Biotech

Bayer Pharmaceuticals​

Experienced Senior Vice President of Pharmaceutical

Stefan Schmidt

Chief Operating Officer

BioAtrium AG

He is heavily involved in the strategic orientation of our CDMO business.

Zorica Dragic

Unit Head Cell Line Screening and Development


Zorica Dragic Arunasalam leads Cell Line Development team in Novartis Biologics Center

Jesse McCool

Chief Technology Officer

Cytovance Biologics ​

Dr. Jesse McCool has over 17 years’ experience in microbial process development, characterization and technology transfer.

Thomas Maischberger

Project Development


Thomas Maischberger is a Process Engineer at ZETA GmbH (Austria) and has experience in industrial microbiology, enzyme technology, and bioprocess optimisation.

Paolo Avalle

Associate Principal Scientist

Merck Sharp & Dohme

Paolo Avalle is and Associate Principal Scientist working for Merck Sharp and Dohme (MSD) in Switzerland.

Bioprocess Innovation Leaders Summit Past Speakers

1 King William Street

London EC4N 7AF

Tel:  0203-858-8185

Fax: 0203-858-8188

  • GBX Events
  • Gbx Events (Summit) You Tube
  • Gbx Events (Summit) Twitter

© 2019 by GBX. Proudly created with GBX Events Ltd.
Company Number: 11782795 - VAT: 317674779 UK